消化管内視鏡狭窄管理機器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の消化管内視鏡狭窄管理機器市場は、2024年～2030年の予測期間にCAGR 5.36％で成長すると予測されます。消化管内視鏡狭窄管理機器の需要は、結腸がん、直腸がん、食道がん、胃食道逆流症（GERD）、過敏性腸症候群（IBS）などのさまざまな消化管（GI）疾患の有病率の増加によって後押しされています。さらに、低侵襲治療機器に対する需要の高まり、消化管障害を引き起こす危険因子の増加、老年人口の急増、機器に関する技術の進歩、製品の承認や発売の増加などが、2024年～2030年の予測期間における消化管内視鏡狭窄管理機器市場の全体的な成長に寄与します。

消化管内視鏡狭窄管理機器の市場力学

GLOBOCAN（2021）によると、2020年に食道がんの新規症例が世界で60万4,100件近く報告されました。同じ資料によると、2020年に世界で新たに胃がんが108万9,103例、胆道がんが11万5,949例報告されました。

さらに、緩和療法やネオアジュバント療法において、消化管内視鏡狭窄管理機器の一種であるステント留置術が、食道、胃十二指腸、大腸の閉塞症状の緩和に極めて重要であることが、さまざまな研究で示されています。したがって、自己拡張型金属ステント（SEMS）の内視鏡挿入は、消化管（GIT）の悪性閉塞や狭窄の管理に向けた最前線の用途であり、市場成長を促進しています。

さらに、International Foundation for Gastrointestinal Disordersが提供した最新の調査によると、世界人口の5～10％が過敏性腸症候群（IBS）に罹患していると推定されています。IBS患者のほとんどは50歳未満です。また、IBS患者の約3人に2人が女性で、約3人に1人が男性です。IBSの有病率の増加は狭窄障害を引き起こす可能性があり、これは消化管内視鏡狭窄管理機器によって治療することができます。

したがって、さまざまな消化器疾患の有病率の増加は狭窄損傷につながり、ひいては消化器内視鏡狭窄管理機器の需要を増加させ、予測期間の消化器内視鏡狭窄管理機器市場を牽引します。

また、ステントや拡張機器は消化管壁を効果的に拡張し保護します。これらの機器は合併症罹患率が低く、技術的成功率も高いため、患者のQOLを向上させます。これらの機器はまた、侵襲性処置の有力な代替手段として機能します。従来の手術と比較すると、低侵襲手術は最先端技術を使って小さな切開口から内臓にアクセスするため、痛みが少なく、感染症のリスクが低く、入院期間が短く、回復が早く、傷跡が少なく、出血もわずかです。それゆえ、世界市場は予測期間にこれらの変数によって牽引される見込みです。したがって、前述の要因が2024年～2030年の予測期間に消化管内視鏡狭窄管理機器の市場全体を推進します。

しかし、管理機器や外科手術に関連する副作用、外科手術を行う医療従事者の不足などが、消化管内視鏡狭窄管理機器市場の成長を抑制する可能性があります。

消化管内視鏡狭窄管理機器市場は、COVID-19パンデミックの期間に大きな影響を受けました。パンデミックの発生により、外来受診がキャンセルされ、緊急性のない入院、診断、外科処置が中止されたからです。その結果、定期的な臨床検査や診断、外科手術が減少しました。しかし、COVID-19ワクチンの開発によりロックダウン規制が緩和され経済情勢が正常化したことで、診断や治療を目的とした外来受診などの通常の医療サービスが再開され、消化器内視鏡的狭窄管理機器市場における製品需要が軌道に乗っています。

消化管内視鏡狭窄管理機器市場のセグメント分析

消化管内視鏡狭窄管理機器市場のタイプセグメントでは、リプロダクティブヘルスカテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、世界中での消化器疾患の有病率の増加と、ステントがもたらす利点によるものと考えられます。ステントとは柔軟で自己拡張可能な中空の金属またはプラスチックのチューブのことで、胃腸（GI）管内の詰まりによる閉塞を開通させるために使用されます。

当レポートでは、世界の消化管内視鏡狭窄管理機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 消化管内視鏡狭窄管理機器市場レポートのイントロダクション

第2章 消化管内視鏡狭窄管理機器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 消化管内視鏡狭窄管理機器市場の主な要因の分析

• 消化管内視鏡狭窄管理機器市場の促進要因
  • 消化器疾患の有病率の上昇
  • 低侵襲処置に対する選好の増加
  • 老年人口の増加は食道の運動障害と唾液分泌の減少に関連している
• 消化管内視鏡狭窄管理機器市場の抑制要因と課題
  • 管理機器や外科手術に関連する副作用
  • 外科手術を行う医療従事者の不足
• 消化管内視鏡狭窄管理機器市場の機会
  • 自己拡張型ニチノールステントなどの技術的優位性の高まり

第5章 消化管内視鏡狭窄管理機器市場のポーターのファイブフォース分析

第6章 消化管内視鏡狭窄管理機器市場レイアウト

• タイプ別
  • バルーン拡張器
  • ステント
  • ブジー拡張器
  • その他
• エンドユーザー別
  • 病院、診療所
  • 外来手術センター
• 地域別
  • 北米の消化管内視鏡狭窄管理機器の市場規模（2021年～2030年）
  • 欧州の消化管内視鏡狭窄管理機器の市場規模（2021年～2030年）
  • アジア太平洋の消化管内視鏡狭窄管理機器の市場規模（2021年～2030年）
  • その他の地域の消化管内視鏡狭窄管理機器の市場規模（2021年～2030年）

第7章 消化管内視鏡狭窄管理機器市場の企業と製品のプロファイル

• Boston Scientific Corporation
• Cook
• Olympus
• HOBBS MEDICAL INC.
• Merit Medical Systems
• CONMED Corporation
• Medi-Globe GmbH
• Teleflex Incorporated
• Ovesco Endoscopy AG
• Richard Wolf GmbH
• ZAVATION
• Laborie.
• Micro-Tech Endoscopy

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Gastrointestinal Endoscopic Stricture Management Device Market in Global (2021-2030)
• Table 3: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Type (2021-2030)
• Table 4: Gastrointestinal Endoscopic Stricture Management Device Market in Global by End-User (2021-2030)
• Table 5: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Geography (2021-2030)
• Table 6: Gastrointestinal Endoscopic Stricture Management Device Market in North America (2021-2030)
• Table 7: Gastrointestinal Endoscopic Stricture Management Device Market in North America by Country (2021-2030)
• Table 8: Gastrointestinal Endoscopic Stricture Management Device Market in the US (2021-2030)
• Table 9: Gastrointestinal Endoscopic Stricture Management Device Market in Canada (2021-2030)
• Table 10: Gastrointestinal Endoscopic Stricture Management Device Market in Mexico (2021-2030)
• Table 11: Gastrointestinal Endoscopic Stricture Management Device Market in Europe (2021-2030)
• Table 12: Gastrointestinal Endoscopic Stricture Management Device Market in Europe by Country (2021-2030)
• Table 13: Gastrointestinal Endoscopic Stricture Management Device Market in France (2021-2030)
• Table 14: Gastrointestinal Endoscopic Stricture Management Device Market in Germany (2021-2030)
• Table 15: Gastrointestinal Endoscopic Stricture Management Device Market in the United Kingdom (2021-2030)
• Table 16: Gastrointestinal Endoscopic Stricture Management Device Market in Italy (2021-2030)
• Table 17: Gastrointestinal Endoscopic Stricture Management Device Market in Spain (2021-2030)
• Table 18: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of Europe (2021-2030)
• Table 19: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific (2021-2030)
• Table 20: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific by Country (2021-2030)
• Table 21: Gastrointestinal Endoscopic Stricture Management Device Market in China (2021-2030)
• Table 22: Gastrointestinal Endoscopic Stricture Management Device Market in Japan (2021-2030)
• Table 23: Gastrointestinal Endoscopic Stricture Management Device Market in India (2021-2030)
• Table 24: Gastrointestinal Endoscopic Stricture Management Device Market in Australia (2021-2030)
• Table 25: Gastrointestinal Endoscopic Stricture Management Device Market in South Korea (2021-2030)
• Table 26: Gastrointestinal Endoscopic Stricture Management Device Market in Rest of Asia-Pacific (2021-2030)
• Table 27: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of the World (2021-2030)
• Table 28: Gastrointestinal Endoscopic Stricture Management Device Market in RoW by Region (2021-2030)
• Table 29: Gastrointestinal Endoscopic Stricture Management Device Market in the Middle East (2021-2030)
• Table 30: Gastrointestinal Endoscopic Stricture Management Device Market in Africa (2021-2030)
• Table 31: Gastrointestinal Endoscopic Stricture Management Device Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Gastrointestinal Endoscopic Stricture Management Device Market in Global (2021-2030)
• Figure 3: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Type (2021-2030)
• Figure 4: Gastrointestinal Endoscopic Stricture Management Device Market in Global by End-User (2021-2030)
• Figure 5: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Geography (2021-2030)
• Figure 6: Gastrointestinal Endoscopic Stricture Management Device Market in North America (2021-2030)
• Figure 7: Gastrointestinal Endoscopic Stricture Management Device Market in North America by Country (2021-2030)
• Figure 8: Gastrointestinal Endoscopic Stricture Management Device Market in the US (2021-2030)
• Figure 9: Gastrointestinal Endoscopic Stricture Management Device Market in Canada (2021-2030)
• Figure 10: Gastrointestinal Endoscopic Stricture Management Device Market in Mexico (2021-2030)
• Figure 11: Gastrointestinal Endoscopic Stricture Management Device Market in Europe (2021-2030)
• Figure 12: Gastrointestinal Endoscopic Stricture Management Device Market in Europe by Country (2021-2030)
• Figure 13: Gastrointestinal Endoscopic Stricture Management Device Market in France (2021-2030)
• Figure 14: Gastrointestinal Endoscopic Stricture Management Device Market in Germany (2021-2030)
• Figure 15: Gastrointestinal Endoscopic Stricture Management Device Market in the United Kingdom (2021-2030)
• Figure 16: Gastrointestinal Endoscopic Stricture Management Device Market in Italy (2021-2030)
• Figure 17: Gastrointestinal Endoscopic Stricture Management Device Market in Spain (2021-2030)
• Figure 18: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of Europe (2021-2030)
• Figure 19: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific (2021-2030)
• Figure 20: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific by Country (2021-2030)
• Figure 21: Gastrointestinal Endoscopic Stricture Management Device Market in China (2021-2030)
• Figure 22: Gastrointestinal Endoscopic Stricture Management Device Market in Japan (2021-2030)
• Figure 23: Gastrointestinal Endoscopic Stricture Management Device Market in India (2021-2030)
• Figure 24: Gastrointestinal Endoscopic Stricture Management Device Market in Australia (2021-2030)
• Figure 25: Gastrointestinal Endoscopic Stricture Management Device Market in South Korea (2021-2030)
• Figure 26: Gastrointestinal Endoscopic Stricture Management Device Market in Rest of Asia-Pacific (2021-2030)
• Figure 27: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of the World (2021-2030)
• Figure 28: Gastrointestinal Endoscopic Stricture Management Device Market in RoW by Region (2021-2030)
• Figure 29: Gastrointestinal Endoscopic Stricture Management Device Market in the Middle East (2021-2030)
• Figure 30: Gastrointestinal Endoscopic Stricture Management Device Market in Africa (2021-2030)
• Figure 31: Gastrointestinal Endoscopic Stricture Management Device Market in South America (2021-2030)
• Figure 32: Market Drivers
• Figure 33: Market Barriers
• Figure 34: Marker Opportunities
• Figure 35: PORTER'S Five Force Analysis

Gastrointestinal Endoscopic Stricture Management Device Market By Type (Balloon Dilator, Stents, Bougie Dilator, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of various gastrointestinal disorders and the surging demand of minimally invasive treatment approach across the globe

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030. The demand for gastrointestinal endoscopic stricture management devices is being boosted by the increasing prevalence of various gastrointestinal (GI) disorders such as colon cancer, rectal cancer, esophageal cancer, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and other. Further, the rising demand for minimally invasive treatment devices, rising figures of GI disorder-causing risk factors, surging geriatric population base, technological advancements about the device, and rising product approvals and launches, among others are thereby contributing to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

Gastrointestinal Endoscopic Stricture Management Device Market Dynamics:

As per GLOBOCAN 2021, in 2020, nearly 604,100 new cases of oesophageal cancer were reported globally. The same source stated that in 2020, 1,089,103 new cases of stomach cancer and 115,949 new cases of biliary cancer were reported, globally.

In addition, various studies show that in palliative and neoadjuvant settings, stenting, a type of gastrointestinal endoscopic stricture management device is crucial in alleviating esophageal, gastroduodenal, or colorectal obstruction symptoms. Thus, the endoscopic insertion of self-expanding metal stents (SEMSs) has a frontline application for managing malignant obstruction or stricture of the gastrointestinal tract (GIT) driving the market growth.

Further, the latest study provided by International Foundation for Gastrointestinal Disorders, estimated that irritable bowel syndrome (IBS) affects 5-10% of the worldwide population. Most persons with IBS are under the age of 50. Also, about 2 in 3 IBS sufferers are female and about 1 in 3 IBS sufferers are male. The increasing prevalence of IBS can lead to stricture damage which can be treated by gastrointestinal endoscopic stricture management devices.

Therefore, the increasing prevalence of various GI disorders will lead to stricture damage, ultimately increasing the demand for gastrointestinal endoscopic stricture management devices, thereby driving the market for gastrointestinal endoscopic stricture management devices during the forecast period.

Also, stents and dilation devices effectively dilate and protect the gastrointestinal wall. The low complication rates and great technical success of these devices improve patient quality of life. These gadgets also function as successful alternatives to invasive procedures. When compared to traditional surgeries, minimally invasive procedures use cutting-edge technology to access internal organs through tiny incisions, resulting in less pain, a low risk of infection, a shorter hospital stay, a speedier recovery, less scarring, and less blood loss. Thus, the global market is probably going to be driven by these variables during the forecast period. Therefore, the aforementioned factors will propel the overall market of gastrointestinal endoscopic stricture management devices during the forecast period from 2024-2030.

However, side effects related to management devices or surgical procedures, scarcity of healthcare experts to perform surgical procedures, and others may restrict the gastrointestinal endoscopic stricture management device market growth.

The gastrointestinal endoscopic stricture management device market was significantly impacted during the period of COVID- 19 pandemic as the outbreak led to the cancellation of outpatient visits and the suspension of non-emergency hospitalization, diagnostic, and surgical procedures. This resulted in a reduced number of routine clinical examinations, diagnoses, and surgical procedures. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits for diagnosis and treatment purposes, thereby bringing the demand for products on track in the gastrointestinal endoscopic stricture management device market.

Gastrointestinal Endoscopic Stricture Management Device Market Segment Analysis:

Gastrointestinal endoscopic stricture management device market by Type (Balloon Dilator, Stents, Bougie Dilator, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the gastrointestinal endoscopic stricture management device market, the reproductive health category is expected to amass a significant revenue share in the year 2023. This can be attributed to the increasing prevalence of GI diseases globally and the advantages the stents provide. A stent is a flexible, self-expandable, hollow metal or plastic tube used to help open any obstruction in the gastrointestinal (GI) tract that is blocked because of any clog formation.

Corrosive upper gastrointestinal strictures (GIS) are common in children, and primarily accidental ingestion, commonly in younger children, contributes to the GIS. In these cases, stents are used. According to various research, resistant caustic strictures are the most common indication of stent placement in children. In most cases, stents can be utilized along with endoscopic dilatation.

Further, the technological advancements in the stents for better outcomes are anticipated to contribute to the segment's growth. For instance, in February 2022, Micro-Tech Endoscopy introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures.

Therefore, the aforementioned factors are predicted to contribute to the increasing demand for this segment thereby driving the growth of the overall gastrointestinal endoscopic stricture management device market during the forecast period.

North America is expected to dominate the overall Gastrointestinal Endoscopic Stricture Management Device Market:

Among all the regions, North America is estimated to account for the largest share of the global gastrointestinal endoscopic stricture management device market in the year 2023. Owing to the factors such as the rising prevalence of gastrointestinal (GI) diseases which lead to increased research & development and manufacturing of numerous devices in the region. Furthermore, high disposable income, sophisticated healthcare infrastructure, and high awareness also helped the market growth in the country.

As per the 2023 report of the American Cancer Society, 106,970 new cases of colon cancer and 46,0850 new cases of rectal cancer are expected to be diagnosed in 2023. Also, as per the same source, about 21,560 new esophageal cancer cases will be diagnosed (17,030 in men and 4,530 in women), in the US, in 2023.

In addition, as per the 2021 report of the International Foundation for Gastrointestinal Disorders (IFFGD), 25 to 45 million people were affected by irritable bowel syndrome in the United States, in 2021.

These gastrointestinal diseases are responsible for strictures in the GI tract, creating the availability of stricture management devices. As gastrointestinal endoscopic stricture management devices, such as balloon dilators, stents, and bougie dilators, provide better outcomes, the need for such devices is increasing in the United States.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, investments, and others also help in boosting regional product demand. For instance, in February 2022, Micro-Tech Endoscopy, a US-based manufacturer, introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures. Thus, such strategic steps help to increase the demand for gastrointestinal endoscopic stricture management devices, thereby driving the North America gastrointestinal endoscopic stricture management device market forward during the forecast period.

Gastrointestinal Endoscopic Stricture Management Device Market Key Players:

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

Recent Developmental Activities in the Gastrointestinal Endoscopic Stricture Management Device Market:

In June 2022, Boston Scientific Corporation entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64%) of M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular, self-expanding metal stents, which Boston Scientific has distributed in Japan since 2015.

In October 2021, Boston Scientific Corporation received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix(TM) Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system.

Key Takeaways from the Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Market size analysis for current gastrointestinal endoscopic stricture management device market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global gastrointestinal endoscopic stricture management device market.

Various opportunities available for the other competitor in the gastrointestinal endoscopic stricture management device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current gastrointestinal endoscopic stricture management device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for gastrointestinal endoscopic stricture management device market growth in the coming future?

Target Audience who can be benefited from this Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Gastrointestinal endoscopic stricture management device products providers

Research organizations and consulting companies

Gastrointestinal endoscopic stricture management device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in the gastrointestinal endoscopic stricture management device

Various End-users who want to know more about the gastrointestinal endoscopic stricture management device market and the latest technological developments in the gastrointestinal endoscopic stricture management device market.

Frequently Asked Questions for the Gastrointestinal Endoscopic Stricture Management Device Market:

1. What is a gastrointestinal endoscopic stricture management device?

Gastrointestinal endoscopic stricture refers to an abnormal narrowing or blocking of sections of the GI tract due to the presence of a tumor or a scar. These strictures are usually treated with endoscopy, a minimally invasive medical method to investigate and operate procedures without making large incisions with the help of various dilation devices and stents.

2. What is the market for global gastrointestinal endoscopic stricture management devices?

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the global gastrointestinal endoscopic stricture management device market?

The demand for gastrointestinal endoscopic stricture management devices is primarily being heightened by the surging statistics of various GI disorders, increasing risk factors, increasing preference for minimally invasive procedures, rising geriatric population associated with disturbances in esophageal motility and a decreased production of saliva, surging product approvals and launches, among others, thereby contribute to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global gastrointestinal endoscopic stricture management device market?

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

5. Which region has the highest share in the gastrointestinal endoscopic stricture management device market?

North America is expected to dominate the overall gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030. Factors such as the rising prevalence of GI disorders, increasing geriatric population, and rising demand for minimally invasive treatment approaches, among the target population, among others will positively impact the North American gastrointestinal endoscopic stricture management device market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about GI disorders also helped the market growth in this region.

Table of Contents

1.Gastrointestinal Endoscopic Stricture Management Device Market Report Introduction

2. Gastrointestinal Endoscopic Stricture Management Device Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Gastrointestinal Endoscopic Stricture Management Device Market Key Factors Analysis

• 4.1. Gastrointestinal Endoscopic Stricture Management Device Market Drivers
  • 4.1.1. Rising prevalence of GI disorders
  • 4.1.2. Increasing preference for minimally invasive procedures
  • 4.1.3. The rising geriatric population is associated with disturbances in esophageal motility and a decreased production of saliva
• 4.2. Gastrointestinal Endoscopic Stricture Management Device Market Restraints and Challenges
  • 4.2.1. Side effects related to management devices or surgical procedures
  • 4.2.2. Scarcity of healthcare experts to perform surgical procedures
• 4.3. Gastrointestinal Endoscopic Stricture Management Device Market Opportunities
  • 4.3.1. Increasing technological advantages such as self-expanding nitinol stent among other

5. Gastrointestinal Endoscopic Stricture Management Device Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Gastrointestinal Endoscopic Stricture Management Device Market Layout

• 6.1. By Type
  • 6.1.1. Balloon Dilator
  • 6.1.2. Stents
  • 6.1.3. Bougie Dilator
  • 6.1.4. Others
• 6.2. By End-User
  • 6.2.1. Hospitals & Clinics
  • 6.2.2. Ambulatory Surgical Centers
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.1. United States Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.2. Canada Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.3. Mexico Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.2. Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.1. France Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.2. Germany Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.4. Italy Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.5. Spain Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.3. Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.1. China Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.2. Japan Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.3. India Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.4. Australia Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.5. South Korea Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.6. Rest of the Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW) Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.1. Middle East Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.2. Africa Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.3. South America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)

7. Gastrointestinal Endoscopic Stricture Management Device Market Company and Product Profiles

• 7.1. Boston Scientific Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Cook
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Olympus
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. HOBBS MEDICAL INC.
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Merit Medical Systems
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. CONMED Corporation
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Medi-Globe GmbH
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Teleflex Incorporated
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Ovesco Endoscopy AG
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Richard Wolf GmbH
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. ZAVATION
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Laborie.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Micro-Tech Endoscopy
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us